SHASUN PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA Quarterly Results    (SHSCH)

Here are the latest quarterly results of SHASUN PHARMA. For more details, see the SHASUN PHARMA financial fact sheet and SHASUN PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

SHASUN PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-13
*
3
Sep-13
*
3
Dec-13
*
3
Mar-14
*
3
Jun-14
*
3
Sep-14
*
3
Dec-14
*
3
Mar-15
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,2732,9693,2533,6333,1373,2003,2503,580 
Other income Rs m9272353119431645 
Turnover Rs m2,3653,0413,2873,6643,1563,2423,2663,624 
Expenses Rs m2,2882,6092,8413,2302,9682,9942,8873,173 
Gross profit Rs m-16323412402172195356421 
Depreciation Rs m133150149162123100118129 
Interest Rs m92111138138116124157129 
Profit before tax Rs m-149134160134-481597207 
Tax Rs m-1030-13000063 
Profit after tax Rs m-46133161104-481497144 
Gross profit margin %-0.710.912.711.15.56.111.011.8 
Effective tax rate %69.10.3-0.522.60.01.40.030.4 
Net profit margin %-2.04.54.92.9-1.50.43.04.0 
Diluted EPS Rs -0.8 2.2 2.7 1.7 -0.8 0.2 1.6 2.4  
Diluted EPS (TTM) Rs 5.7 5.0 6.3 5.9 5.8 3.8 2.8 3.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC  INDRAPRASTHA MEDICAL  DR. REDDYS LAB  

Compare SHASUN PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC  INDRAPRASTHA MEDICAL  DR. REDDYS LAB  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Zoomed 613 Points Today(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note.

Views on news

Gland Pharma Q4 results: Net profit rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

Cipla's Q4 Update: Net Profit Surges 68%; Company to Pay Rs 5 Dividend (Views On News)

May 17, 2021

Here's a rundown on the latest quarterly results of Cipla.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS